DEMONSTRATING YOUR MEDICINE S VALUE TO ALL STAKEHOLDERS TRUSTED COMMERCIALIZATION AND MARKET ACCESS EXPERTISE

Transcription

1 CATALYSTS DRIVING SUCCESSFUL DECISIONS IN LIFE SCIENCES DEMONSTRATING YOUR MEDICINE S VALUE TO ALL STAKEHOLDERS TRUSTED COMMERCIALIZATION AND MARKET ACCESS EXPERTISE

2 WHEN COMMERCIALIZING A MEDICINE, IT S ALL ABOUT ACHIEVING THE BROADEST MARKET ACCESS AT THE RIGHT PRICE

3 Kantar Health offers you seasoned market access consultants with unique stakeholder insights that enable the development of the most compelling value propositions and winning strategies. Our custom solutions include: + + Stakeholder mapping + + Qualitative multicountry payer and stakeholder research + + Value proposition optimization and message validation + + Qualitative and quantitative pricing research + + Market access input to due diligence, licensing and acquisition decisions

4 KANTAR HEALTH MARKET ACCESS SUBSTANTIATING A COMPELLING VALUE PROPOSITION ACROSS THE PRODUCT LIFECYCLE Building a compelling value proposition begins in early product development. Achieving and sustaining market access requires a sound global strategy. You need to ensure you ve identified the right patient, drug, dose and duration of treatment. Your value proposition must be highly compelling and able to withstand the rigors of a dynamic and increasingly demanding reimbursement environment. Without a solid global market access strategy, you run the risk of reimbursement delay, restricted product access and a muddled payer value proposition all of which result in suboptimal pricing. throughout the product lifecycle. Market access is not just a milestone but a dynamic state that Kantar Health will help you achieve with continuous value development and communication. Today, it s no longer just about listening to physicians. Trusted market access strategies are required for achieving long-term commercial success, as they demonstrate value to a diverse range of stakeholders and influencers such as patients and payers. At Kantar Health, we believe the key to market access success is substantiating a compelling value proposition across the product lifecycle. We help you identify, validate and optimize value early in product development, and we support you in quantifying and substantiating it Payer Clinician Patient Policy Maker Advocacy groups Caregiver

5 COMMERCIAL SUCCESS MEANS DEMONSTRATING VALUE TO A RANGE OF STAKEHOLDERS

6

7 OUR STRENGTHS We leverage our market access expertise, providing consultation that enables you to: + + Better understand the payer environment and stakeholder value drivers across markets + + Develop value propositions that resonate with key national, regional and local stakeholders + + Understand how to substantiate the value proposition with clinical, economic and observational study data + + Identify optimal pricing strategies for your products to maximize your revenue and sales targets + + Utilize payer inputs to inform realistic scenarios affecting overall product demand We pride ourselves on delivering holistic, calibrated and nuanced insights and solutions that stretch far beyond simple stakeholder interviews. Our proprietary methodologies seamlessly integrate advanced analytics and quantitative approaches to deliver the best customized solutions to our clients. Kantar Health s commercialization and market access capabilities include: + + Care delivery landscape assessments and stakeholder mapping across all markets + + Product value assessment and gap analysis + + Value proposition optimization, message validation and communication + + Qualitative and quantitative pricing research + + Pre-Phase II-III payer assessment of clinical trial program + + Analogue analysis to support launch optimization + + Patient financial assistance strategies Our syndicated offerings include: + + Oncology Market Access US + + Oncology Market Access Europe

8 REAL-WORLD EVIDENCE SOLUTIONS ADVANCING HEALTHCARE AND DRIVING BETTER PATIENT OUTCOMES Market access forms an integral part of our holistic real-world evidence solutions. Kantar Health is a world-class evidence specialist with proprietary databases spanning the globe. Whether your need originates from market access, regulatory/ medical affairs, pharmacovigilance or health economics and outcomes research, we can help you generate evidence to support the success of your product through its lifecycle. ABOUT KANTAR HEALTH Kantar Health is a leading global healthcare consulting firm and trusted advisor to many of the world s leading pharmaceutical, biotech and medical device and diagnostic companies. It combines evidence-based research capabilities with deep scientific, therapeutic and clinical knowledge, commercial development knowhow, and brand and marketing expertise to help clients evaluate opportunities, launch products and maintain brand and market leadership. Our advisory services span three areas critical to bringing new medicines and pharmaceutical products to market commercial development, clinical strategies and marketing effectiveness. For more information, please visit